Medison is changing the commercialization paradigm for highly innovative therapies in international markets

Medison Israel was established in 1996 and is a leading pharma company in Israel. Medison Israel commercializes highly innovative therapies, helping to save and improve the lives of patients suffering from the most challenging diseases by accelerating access to the best available novel treatments.

Medison Israel has deep expertise in local regulatory, market access, marketing, medical affairs and commercial excellence. It offers an affiliate-like partnership model and has long lasting partnerships with a wide range of leading pharmaceutical and biotech companies.

Medison European Partner Markets is part of Medison, a global pharma company focused on providing access to highly innovative therapies to patients in international markets.

Medison European Partner Markets commercializes highly innovative therapies across Central Eastern Europe, Balkans, Baltics, Greece & Cyprus, helping to save and improve the lives of patients suffering from the most challenging diseases by accelerating access to the best available novel treatments.

Medison European Partner Markets has deep expertise in local regulatory and market access with uncompromising compliance excellence.

With established presence and local offices across the entire region, Medison European Partner Markets offers an affiliate-like partnership and tailored-solutions for country-specific and regional commercialization, enabling emerging biotech companies to navigate through local complexities and to expand their reach to patients across markets.

Medison Canada is a pioneer in the Canadian healthcare landscape as the first to focus solely on commercializing highly innovative therapies, helping to save and improve the lives of Canadian patients suffering from the most challenging diseases by accelerating access to the best available novel treatments.

Medison Canada has deep expertise in local regulatory and market access, combined with international commercial excellence.

With established national presence, Medison Canada offers an affiliate-like partnership, enabling emerging biotech companies to expand their reach to the Canadian market.

Medison Australia is part of Medison, a global pharma company focused on providing access to highly innovative therapies to patients in international markets.

Medison Australia is a pioneer in the healthcare landscape in Australia and New Zealand as the first to focus solely on commercializing highly innovative therapies, helping to save and improve the lives of patients in the region suffering from the most challenging diseases by accelerating access to the best available novel treatments.

With established regional presence and deep expertise in local regulatory and market access, Medison Australia offers an affiliate-like partnership, enabling emerging biotech companies to expand their reach into the Australia-New Zealand market.

Medison LATAM is part of Medison, a global pharma company focused on providing access to highly innovative therapies to patients in international markets.

Medison LATAM commercializes highly innovative therapies across the South and Central America and the Caribbean markets. With its unique business platform, offering tailored solutions for country-specific and regional commercialization, Medison enhances saving and improving the lives of patients in the region suffering from the most challenging diseases by accelerating access to the best available novel treatments.

With our regional presence and deep expertise in local regulatory and market access, Medison LATAM offers an affiliate-like partnership, enabling emerging biotech companies to expand their reach into Latin American markets.